Quell Therapeutics
Seedtable Score
60
Startups
2
Funding Rounds
2
Investors
$201.03m
Money raised
Overview
Quell Therapeutics, based in London, focuses on advanced cell therapies to treat various illnesses, positioning itself strongly in the biotech sector. Their cutting-edge cellular technology outperforms traditional treatments and basic cell therapy options, which often lack effectiveness and innovation. Using a B2B model, Quell targets enterprises in related sectors to advance their solutions. Support from investors like AlbionVC and Point72 Ventures adds credibility and financial backing. Quell's innovative approach offers a promising alternative to conventional pharmaceuticals for tackling complex health issues.
- Website: https://quell-tx.com
- Business model: b2b
- Company size: 101 - 251 employees
- Headquarters: London, UK
- Founded: 2019
- Social accounts: Linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Investors (2)
Funding
Funding series
Funding Series Analysis
The company Quell Therapeutics has raised a total of $201.03m in funding over 2 rounds.
Key Insights:
- Series B: $156m
- Series A: $45.03m
Quell Therapeutics Series A (2019, $45M)
$45.03m
Quell Therapeutics Series B (2021, $156M)
$156m